MAPK3 and cancer: Along with a negative vehicle [i.e., dimethyl sulfoxide (DMSO)] control, our data collectively support a notion that EGF–ERK1/2 signaling pathways indeed play an essential role in the regulation of large-sized glucosomes in cancer cells.